Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
T J Wilt
Dr T J Wilt, University of Minnesota School of Medicine, Minneapolis, MN, USA; email@example.com
In men with localised prostate cancer, what is the evidence for effectiveness and harm of various treatments?
Included studies evaluated treatments for localised prostate cancer (tumour stage T1 or T2). Outcomes were all-cause and disease-related mortality, biochemical and clinical progression, and adverse events.
Cochrane Library (Issue 3, 2007) and Cochrane Review Group in Prostate Diseases and Urologic Malignancies specialised register (Nov 2007) were searched for randomised controlled trials (RCTs). Other sources were searched for observational studies. 18 RCTs (n = 6482, mean age 63–73 y, mean follow-up 3–23 y), 1 pooled analysis of 3 RCTs (n = 8113, mean age 67 y, median follow-up 5.4 y), …
Source of funding: Agency for Healthcare Research and Quality.